Immune-Mediated Inflammatory Diseases Clinical Trials

Accelerate your IMID clinical development program with a global leader in immune-mediated disorder research.

Creating a Customized Approach for Your Success

At Worldwide Clinical Trials, we understand that each immune-mediated inflammatory disorder (IMID) presents unique challenges among these multifactorial diseases. Our dedicated teams are committed to providing tailored solutions that align with your specific needs, ensuring the success of your clinical program. From initial trial design to market entry, our experts are with you every step of the way.

We integrate seamlessly with your team, bringing medical, scientific, and operational expertise together to foster a collaborative partnership focused on mutual success. Our comprehensive approach spans a wide range of IMID indications, offering extensive experience in managing complex trials across multiple therapeutic areas.

Comprehensive IMID Clinical Development Services

For specific information about how we can support your study, get in touch

We are dedicated to providing the best possible solutions and cutting-edge resources for your IMID clinical trial. Our team of experts specializes in gastroenterology, hematology, rheumatology, and respiratory conditions, ensuring your study receives unparalleled support. Discover how our comprehensive capabilities can drive your success.

Phase I Expertise

Precision in Phase I trial designs.
Efficient cohort management and optimization.
Comprehensive sample and logistics management.
Specialized bioanalytical lab services.

Adaptive & Complex Trial Designs

Expertise in adaptive and complex Phase I-II trials.
Agile data review processes for rapid decision-making.
Global expansion capabilities with a focus on timely execution.

Regulatory Support

In-depth global and local regulatory expertise.
Strategic engagements with regulatory agencies.
Comprehensive strategies for regulatory navigation.

Global IMID Clinical Trials

Extensive global footprint in optimal and emerging markets.
Established pathways for efficient delivery with central labs and imaging.
Readiness for regulatory inspections.

Patient-Centric Approaches

Innovative enrollment strategies to minimize patient burden.
Dedicated patient navigators and partnerships with advocacy organizations.
Focused strategy on diversity and inclusion.

Expertise in Cellular & Genetic Therapies

Modality-specific support for diverse treatment approaches.
Experience in both adult and pediatric phases.
Specialization in various routes of administration.

Biomarker and Personalized Medicine

Strong alliances with reference and specialty labs.
Expertise in executing preclinical and screening protocols.
Advanced logistics and sample management capabilities.
Data-driven strategies for optimizing enrollment through genetic epidemiology.

Take a deeper look at
our capabilities

Your Partner in IMID Clinical Success

Our vast experience and specialized knowledge in immune-mediated inflammatory diseases make us the ideal partner for your clinical trial. We have the tools, expertise, and global reach to ensure your trial’s success, from concept to commercialization.

Therapeutic-Informed Approach

We have expertise across a broad range of IMID conditions, including rheumatoid arthritis, lupus, inflammatory bowel disease, connective tissue disorders, atopic dermatitis, psoriasis, osteoporosis, rare inflammatory disease, asthma, and COPD. We also offer support for small molecules, biologics (including biosimilars), and advanced therapies like gene and cellular therapies.

Award-Winning Project Teams

Our teams are recognized for their excellence and commitment to delivering quality outcomes. They are dedicated to upholding a legacy of success and being accessible to the sponsors they support.

Managing Complex Programs

We specialize in supporting complex and innovative trials, providing resources and relationships necessary for success. Our expertise includes handling intricate protocol developments and ensuring seamless trial execution.

See what our clients have to say

Your experience is important to us.

“Worldwide is an important partner for us. We have a long history with positive experiences… so the relationship is on a fantastic foundation. We also believe in the value of long-term strategic partnerships and certainly see Worldwide as one of our few strategic partners in the future.”

Late Phase: Midsize Biotech Customer Sr. Director of Clinical Operations

“The top reasons why we selected Worldwide is that they showed they had the experience and how the team interacted together, all of that collaboration spirit. They weren’t the biggest, and they weren’t the smallest, so it was balancing having the ability to do our trials without us being just a number vs. big CROs that have bigger clients.”

Late Phase: Small Biopharma Customer Vice President of Clinical Operations

“Worldwide is an important strategic partner for our company. Worldwide has performed well on our recent clinical studies, and I see no issues that would prohibit us from awarding more clinical studies to them in the future.“  

Late Phase: Small Biotech Customer Vice President of Clinical Operations

Meet Our IMID Experts

Our team delivers tailored and pragmatic advice regardless of the size or complexity of the project. Our collaborative, customized project teams with phase- and indication-specific expertise develop successful strategies for even the most novel therapies.

Meet our team and learn how our approach can transform your IMID trial.